Frontlight ResearchEarly access
Trial site
Epamed s.r.o.
- 9running trials
- 3closed trials
The trials here
What the 12 trials at this site are about, from their registry records.
- Conditions
- Alzheimer disease6 trials
- Depression3 trials
- Schizophrenia3 trials
- Bipolar disorder1 trial
- Phase
- Phase 38 trials
- Phase 23 trials
- Phase 2/31 trial
- Status
- Recruiting8 trials
- Completed3 trials
- Not yet recruiting1 trial
- Lead sponsor
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company2 trials
- Neurocrine Biosciences2 trials
- Boehringer Ingelheim International GmbH1 trial
- Bristol-Myers Squibb1 trial
- Exciva GmbH1 trial
- and 5 more
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
Recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Alzheimer disease5 recruiting
- Depression2 recruiting
- Schizophrenia2 recruiting
- Bipolar disorder1 recruiting
Closed trials
Completed
Completed
Completed
Site data: EU CTIS (euclinicaltrials.eu)Updated 13 Nov 2026